Company Search:
Advanced Search
Sponsored Links
Oramed Pharmaceuticals Incorporation Company Snapshot
Oramed Pharmaceuticals Incorporation operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Oramed Pharmaceuticals Incorporation with three other pharmaceutical manufacturers in Middle East: Sabaa International Company for Pharmaceutical & Chemical Industries SAE of EGYPT (2019 sales of 67.33 million Egyptian Pounds [US$4.29 million] ), Univo Pharmaceuticals Ltd (824,000.00 Israel Shekels [US$243,574.40 ] ), and Can Fite Biopharma Ltd (7.22 million Israel Shekels [US$2.13 million] ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Oramed Pharmaceuticals Incorporation
  Stock Performance Chart for Oramed Pharmaceuticals Incorporation
  Stock Data: Recent Stock Performance:
  Current Price (10/23/2020): 8.62
(Figures in Israel Shekels)
1 Week -4.7%   13 Weeks -13.4%  
4 Weeks -37.6%   52 Weeks -22.8%  
Oramed Pharmaceuticals Incorporation Key Data:
  Ticker: ORMP Country: United States
  Exchanges: OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 9,803,781
(Year Ending Jan 2020).
Employees: 13
  Currency: Israel Shekels Market Cap: 200,684,156
  Fiscal Yr Ends: August Shares Outstanding: 23,277,039
  Share Type: Ordinary Closely Held Shares: 4,195,811
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.